Search Results - "Racette, B. A."

Neurologist care in Parkinson disease: A utilization, outcomes, and survival study by WILLIS, A. W, SCHOOTMAN, M, EVANOFF, B. A, PERLMUTTER, J. S, RACETTE, B. A

“…To investigate the utilization of neurologist providers in the treatment of patients with Parkinson disease (PD) in the United States and determine whether…”
Get full text

Prevalence of parkinsonism and relationship to exposure in a large sample of Alabama welders by RACETTE, B. A, TABBAL, S. D, JENNINGS, D, GOOD, L, PERLMUTTER, J. S, EVANOFF, B

“…To estimate the prevalence of parkinsonism in welders in Alabama and to compare this prevalence with that in a general population sample. The authors screened…”
Get full text

Reduced uptake of [18 F]FDOPA PET in asymptomatic welders with occupational manganese exposure by CRISWELL, S. R, PERLMUTTER, J. S, VIDEEN, T. O, MOERLEIN, S. M, FLORES, H. P, BIRKE, A. M, RACETTE, B. A

“…Welding exposes workers to manganese (Mn) fumes, but it is unclear if this exposure damages dopaminergic neurons in the basal ganglia and predisposes…”
Get full text

Novel THAP1 sequence variants in primary dystonia by XIAO, J, ZHAO, Y, VAN GERPEN, J. A, SIMON, D. K, TARSY, D, HEDERA, P, TRUONG, D. D, FREI, K. P, DEV BATISH, S, BLITZER, A, PFEIFFER, R. F, GONG, S, BASTIAN, R. W, LEDOUX, M. S, PERLMUTTER, J. S, RACETTE, B. A, TABBAL, S. D, KARIMI, M, PANIELLO, R. C, WSZOLEK, Z. K, UITTI, R. J

“…THAP1 encodes a transcription factor (THAP1) that harbors an atypical zinc finger domain and regulates cell proliferation. An exon 2 insertion/deletion…”
Get full text

Welding-related parkinsonism: Clinical features, treatment, and pathophysiology by RACETTE, B. A, MCGEE-MINNICH, L, MOERLEIN, S. M, MINK, J. W, VIDEEN, T. O, PERLMUTTER, J. S

“…To determine whether welding-related parkinsonism differs from idiopathic PD. Welding is considered a cause of parkinsonism, but little information is…”
Get full text

Haplotypes and gene expression implicate the MAPT region for Parkinson disease : The GenePD Study by TOBIN, J. E, LATOURELLE, J. C, RACETTE, B. A, PERLMUTTER, J. S, WATTS, R, GUTTMAN, M, BAKER, K. B, GOLDWURM, S, PEZZOLI, G, SINGER, C, SAINT-HILAIRE, M. H, HENDRICKS, A. E, LEW, M. F, WILLIAMSON, S, NAGLE, M. W, WILK, J. B, MASSOOD, T, LARAMIE, J. M, DESTEFANO, A. L, LITVAN, I, NICHOLSON, G, CORBETT, A, ISAACSON, S, KLEIN, C, BURN, D. J, CHINNERY, P. F, PRAMSTALLER, P. P, SHERMAN, S, AL-HINTI, J, DRASBY, E, NANCE, M, MOLLER, A. T, OSTERGAARD, K, ROXBURGH, R, SUCHOWERSKY, O, SNOW, B, SLEVIN, J. T, CAMBI, F, GUSELLA, J. F, MYERS, R. H, SHILL, H. A, GOLBE, Li, MARK, M. H, GROWDON, J. H, WOOTEN, G. F

“…Microtubule-associated protein tau (MAPT) has been associated with several neurodegenerative disorders including forms of parkinsonism and Parkinson disease…”
Get full text

Epidemiology and neuropsychiatric manifestations of Young Onset Parkinson's Disease in the United States by Willis, A.W, Schootman, M, Kung, N, Racette, B.A

“…Abstract Background To determine the demographic distribution of Young Onset Parkinson's Disease (YOPD) in the United States and to quantify the burden of…”
Get full text

Pathologic correlates of supranuclear gaze palsy with parkinsonism by Martin, W.R.W, Hartlein, J, Racette, B.A, Cairns, N, Perlmutter, J.S

“…Abstract Introduction Supranuclear gaze palsy (SGP) is a classic clinical feature of progressive supranuclear palsy (PSP) but is not specific for this…”
Get full text

BDNF genetic variants are associated with onset age of familial Parkinson disease : GenePD Study by KARAMOHAMED, S, LATOURELLE, J. C, GUTTMAN, M, NICHOLSON, G, WILK, J. B, SAINT-HILAIRE, M, DESTEFANO, A. L, PRAKASH, R, TOBIN, S, WILLIAMSON, J, SUCHOWERSKY, O, LABELL, N, RACETTE, B. A, GROWDON, B. N. J, SINGER, C, WATTS, R, GOLDWURM, S, PEZZOLI, G, BAKER, K. B, GIROUX, M. L, PRAMSTALLER, P. P, BURN, D. J, CHINNERY, P, PERLMUTTER, J. S, SHERMAN, S, VIEREGGE, P, LITVAN, I, GUSELLA, J. F, MYERS, R. H, PARSIAN, A, WOOTEN, G. F, LEW, M, KLEIN, C, SHILL, H, GOLBE, L. I, MARK, M. H

“…Brain-derived neurotrophic factor (BDNF) stimulates neuronal growth and protects nigral dopamine neurons in animal models of Parkinson disease (PD). Therefore,…”
Get full text

Pathophysiology of parkinsonism due to hydrocephalus by Racette, B A, Esper, G J, Antenor, J, Black, K J, Burkey, A, Moerlein, S M, Videen, T O, Kotagal, V, Ojemann, J G, Perlmutter, J S

“…We report a patient with hydrocephalus who developed levodopa responsive parkinsonism and severe bradyphrenia associated with shunt malfunction and revision…”
Get full text

Ptosis as a remote effect of therapeutic botulinum toxin B injection by RACETTE, B. A, LOPATE, G, GOOD, L, SAGITTO, S, PERLMUTTER, J. S

“…The authors report a patient with cervical dystonia, previously treated with botulinum toxin A (BTX-A), who developed bilateral ptosis and difficulty with…”
Get full text

Herbicide exposure modifies GSTP1 haplotype association to parkinson onset age : The GenePD study by WILK, J. B, TOBIN, J. E, SINGER, C, GROWDON, J. H, LATOURELLE, J. C, SAINT-HILAIRE, M. H, DESTEFANO, A. L, PRAKASH, R, WILLIAMSON, S, BERG, C. J, SUN, M, GOLDWURM, S, SUCHOWERSKY, O, PEZZOLI, G, RACETTE, B. A, PERLMUTTER, J. S, PARSIAN, A, BAKER, K. B, GIROUX, M. L, LITVAN, I, PRAMSTALLER, P. P, NICHOLSON, G, BURN, D. J, SHILL, H. A, CHINNERY, P. F, VIEREGGE, P, SLEVIN, J. T, CAMBI, F, MACDONALD, M. E, GUSELLA, J. F, MYERS, R. H, GOLBE, L. I, KLEIN, C, WOOTEN, G. F, LEW, M. F, MARK, M. H, GUTTMAN, M, WATTS, R. L

“…Polymorphisms in the glutathione S-transferase pi gene (GSTP1), encoding GSTP1-1, a detoxification enzyme, may increase the risk of Parkinson disease (PD) with…”
Get full text

Evaluation of a screening questionnaire for genetic studies of Parkinson's disease by Racette, Brad A., Rundle, Melissa, Parsian, Abbas, Perlmutter, Joel S.

“…A screening questionnaire with high sensitivity for detection of Parkinson's disease would make it easier to identify undiagnosed, yet affected, family members…”
Get full text

Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson's disease from the GenePD study by Karamohamed, Samer, Golbe, L.I., Mark, M.H., Lazzarini, A.M., Suchowersky, O., Labelle, N., Guttman, Mark, Currie, L.J., Wooten, G.F., Stacy, M., Saint-Hilaire, M., Feldman, R.G., Liu, J., Shoemaker, C.M., Wilk, J.B., DeStefano, A.L., Latourelle, J.C., Xu, G., Watts, R., Growdon, J., Lew, M., Waters, C., Vieregge, P., Pramstaller, P.P., Klein, C., Racette, B.A., Perlmutter, J.S., Parsian, A., Singer, Carlos, Montgomery, E., Baker, K., Gusella, J.F., Herbert, A., Myers, R.H.

“…Parkinson's disease (PD) is a neurodegenerative disorder in which relatives of the probands are affected approximately 4 times as frequently as relatives of…”
Get full text

A multi-incident, old-order Amish family with PD by RACETTE, B. A, RUNDLE, M, SUAREZ, B, PARSIAN, A, PERLMUTTER, J. S, WANG, J. C, GOATE, A, SACCONE, N. L, FARRER, M, LINCOLN, S, HUSSEY, J, SMEMO, S, LIN, J

“…PD is largely a sporadic condition of unknown etiology, but specific inherited mutations are a cause of PD. To describe a large, multi-incident Amish pedigree…”
Get full text

Preoperative treatment with botulinum toxin to facilitate cervical fusion in dystonic cerebral palsy : Report of two cases by RACETTE, B. A, LAURYSSEN, C, PERLMUTTER, J. S

“…The authors report the use of high-dose botulinum toxin A for muscle relaxation prior to surgery for cervical spine fixation in two patients with dystonic…”
Get full text

Efficacy and safety of a new bulk toxin of botulinum toxin in cervical dystonia: a blinded evaluation by Racette, B A, McGee-Minnich, L, Perlmutter, J S

“…We investigated the efficacy and safety of botulinum toxin A (BTX) manufactured from a new bulk strain for the treatment of cervical dystonia. This was a…”
Get more information

Association of α -synuclein gene haplotypes with Parkinson's disease by Parsian, A.J, Racette, B.A, Zhao, J.H, Sinha, R, Patra, B, Perlmutter, J.S, Parsian, A

“…Abstract In a previous study, we detected an association between a dinucleotide repeat (Rep1) in the α -Synuclein (SNCA) gene and sporadic Parkinson's disease…”
Get full text

Randomized controlled trial of ethyl-eicosapentaenoic acid in Huntington disease: the TREND-HD study

“…To determine whether ethyl-eicosapentaenoic acid (ethyl-EPA), an omega-3 fatty acid, improves the motor features of Huntington disease. Six-month multicenter,…”
Get more information

Thalamic stimulation for primary writing tremor by RACETTE, Brad A, DOWLING, Joshua, RANDLE, Jennifer, MINK, Jonathan W

“…We report a patient with primary writing tremor whose tremor was treated with thalamic stimulation. He had undergone trials of multiple oral medications with…”
Get full text